NSS Labs Announces Group Test Results for Enterprise EPP

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NSS Labs Announces Group Test Results for Enterprise EPP Socially Engineered Malware and Exploits & Evasions

AUSTIN, TX--(Marketwired - Nov 10, 2015) -  NSS Labs, the world's leading information security research and advisory company, announced today the results of its 2015 Enterprise EPP Socially Engineered Malware (SEM), and Exploits and Evasions group tests.

While some exploits and malware are filtered and remediated by the layers of network-based defense such as next generation firewalls and secure web gateways, much is still making it through these security layers to the endpoint. For mobile workers, endpoint protection (EPP) products may be the only layer of security protecting their devices.

SEM, or malicious software programs or applications that are downloaded from websites and URLs are on the rise, putting organizations even more at risk. In the SEM group test, average protection ranged from 82.8% to 100% effectiveness. This demonstrates that several EPP products provide strong anti-malware defenses.

However, in the Exploits and Evasions group test, 80% of the products lacked comprehensive anti-exploit attack mitigation capabilities for browser-based exploits delivered against Internet Explorer and Firefox. These client-side exploits allow attackers to remotely control compromised systems. Additionally, 60% of the EPP products were bypassed using vulnerabilities that are between three and five years old, which puts a significant number of Windows XP-based systems at risk. Windows XP-based systems continue to hold 15% of the OS market share and are still used in critical infrastructures verticals such as defense, energy, healthcare, telecommunication and finance.

"Multiple changes in the Internet threat landscape coupled with changes in how people work remotely are heightening the importance of endpoint protection being a critical line of defense," said Mike Spanbauer, VP of Research for NSS Labs.

Key findings:

  • There was a considerable difference between the products with the most effective protection and the least effective protection. Product selection may be the single biggest factor determining whether or not a company will be compromised.
  • The highest exploit block rate was 98.8% while the lowest was 11%. 2 vendors received an NSS Recommended rating while 4 received an NSS Caution rating.
  • 20% of the products tested for SEM were able to unable to act on threats immediately on access or upon download.
  • Only 4 of the 11 vendors tested for SEM provided instantaneous protection against new threats.
  • Most EPP products are still not protecting against specific file-format vulnerabilities such as VLC media player, QuickTime, and RealTime Player.
  • Windows XP-based endpoint vendor support is on the decline

Tested Products in Security Stack: Socially Engineered Malware

  • Bitdefender Endpoint Security v5.3.15.539
  • ESET Endpoint Security v 6.1.2109.0
  • Fortinet FortiClient v5.2.3.0633
  • F-Secure Client Security Premium 11.60 build 284
  • G DATA Security Client v13.1.0.224
  • Kaspersky Endpoint Security v10.2.2.10535
  • McAfee Endpoint Protection v8.0
  • Panda Endpoint Security v7.20.0
  • Sophos Endpoint Security v10.3
  • Symantec Endpoint Security v12.1.4112.4156
  • Trend Micro Endpoint Security v11.0.1057

Tested Products in Exploits & Evasions

  • Bitdefender Endpoint Security v5.3.2
  • ESET Endpoint Antivirus v6.1.2
  • Fortinet Forticlient v.5.2.3.06331
  • F-Secure Client Security Premium v11.6
  • GDATA Endpoint Protection v13.1.2
  • Kaspersky Endpoint Security 10 for Windows v10.2.2
  • McAfee VirusScan Enterprise v8.82
  • Panda Endpoint Protection v7.2
  • Sophos Endpoint Security and Control v10.3
  • Symantec Endpoint Protection v12.1
  • Trend Micro OfficeScan v11.0

About NSS Labs, Inc.

NSS Labs, Inc. provides insight that helps businesses become more secure. Focusing exclusively on IT security, NSS delivers value through its world-leading security product testing laboratory, security research and analyst services, and Cyber Advanced Warning System™ - a cloud service offering that leverages product testing and an adversary engagement network. Through these capabilities, NSS delivers unparalleled cyber risk guidance to CEOs, CIOs, CISOs, and information security professionals from many of the largest and most demanding enterprises around the world. For more information, visit www.nsslabs.com .

Contact: Tom Resau W2 Communications Phone: +1 (703) 877-8103 tom@w2comm.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 72

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
APEC's Shenzhen Signal Is Bigger Than a Two-Day Summit

Updated Category News Views 92

Shenzhen spent two days trying to turn regional anxiety into a workable agenda. The APEC CEO Summit 2026, held November 17 and 18 at the Qianhai International Convention Center, brought together more than 2,000 political and business leaders from all 21 APEC economies and 13 economies outside the group. That is a serious room, not a ceremonial photo line. Still, investors...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 81

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 65

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 15

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 71

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 34

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading

Top 5 Most Recently Viewed Articles

Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 327

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
Nebius Secures $700 Million to Accelerate AI Infrastructure Growth

Updated Category News Views 269

Nebius Secures $700 Million to Accelerate AI Infrastructure Growth Nebius Group N.V. (“Nebius Group”, “Nebius” or the “Company”; NASDAQ:NBIS), a prominent player in AI infrastructure, has made an exciting announcement regarding a substantial private placement financing. In a strategic move to bolster its operations, the company has secured USD 700 million from...

Continue Reading
Xenon Pharmaceuticals Welcomes Tucker Kelly as CFO

Updated Category News Views 183

Xenon Pharmaceuticals Welcomes Tucker Kelly as CFO Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a biopharmaceutical company specializing in neuroscience, has made a significant move by appointing Tucker Kelly as the new Chief Financial Officer (CFO). This decision signals the company's commitment to strategic financial management as it gears up for the commercialization of...

Continue Reading
Brookfield Makes Big Moves in Japan's Real Estate Market

Updated Category News Views 302

Brookfield's Bold Ventures into Japan's Real Estate Landscape Canadian investment firm Brookfield Asset Management (TSX: BAM) has recently made headlines with its significant real estate endeavors in Japan, closing two major deals that amount to a staggering $1.6 billion. The Significant Investments Overview The recent acquisitions involve a noteworthy stake in the iconic...

Continue Reading
Pacira BioSciences Facing Legal Challenges and Investor Updates

Updated Category News Views 170

Legal Proceedings Impacting Pacira BioSciences, Inc. Shareholders of Pacira BioSciences, Inc. should be aware of a significant class action lawsuit that is currently unfolding. This lawsuit, noted for its complexity, aims to address allegations of securities fraud impacting investors. The firm representing the investors, is Levi & Korsinsky, a well-established legal group...

Continue Reading